コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 coupling of acetaldehyde with excess surface ethoxy.
2 iophene-2-carboxamide, 5-methoxy-3-(1-methyl ethoxy)-1-oxide (PD 144795) block the induction of p53 a
3 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) as effective sul
4 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) as effective sul
6 erences in the ability of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) to irreversibly inact
8 onaphthalene (7-OH-DPAT), 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), or fluphenazine were
9 esistant to alkylation by 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), which readily alkyla
10 the receptor inactivator N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 50 nmol/0.5 ml one da
12 dopamine antagonist EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline), into nucleus accumbens but
15 action of 4,5-dimethyl-2-(2-oxo-1,2-diphenyl)ethoxy-1,3,2-dioxaphospholane, bearing a carboxyl group
17 thyl-6-benzyloxy-3Z,5E-hexadienoyl)- 1-aza-2-ethoxy-1,3-butadiene (40) undergoes cycloaddition to pro
18 an exclusive 6-endo-dig iodocyclization of 3-ethoxy-1-(2-alkoxyphenyl)-2-yn-1-ols and 5-endo-dig iodo
22 itial lead, T3.5 (3-chloro-6-(2-diethylamino-ethoxy)-10-(2-diethylamino-ethyl)-acridone), demonstrate
23 4) (from 6 treated with FeSO4.7H2O) forms 12-ethoxy-11,12-dihydro-6H-6,12-methanodibenzo[b,f][1,5]thi
24 , 2-propynyl-17alpha-methylestradiol (39), 2-ethoxy-17-(1'-methylene)estra-1,3,5(10)-triene-3-ol (50)
25 ylene)estra-1,3,5(10)-triene-3-ol (50) and 2-ethoxy-17alpha-methylestradiol (51) showed similar or gr
28 ed gallium(III) complex, gallium(III)-(bis(3-ethoxy-2-hydroxy-benzylidene)-N,N'-bis(2,2-dimethyl-3- a
29 nd trans-[5,5'-(1,2-ethanediyl diimino)bis(2-ethoxy-2-methyl-3-oxo-4-pentenyl)]bis[dimethyl(3- methox
30 tions by using eosin Y as the catalyst and N-ethoxy-2-methylpyridinium tetrafluoroborate as the oxida
31 rboxamide (1) to lead compound 6-methyl-N-(4-ethoxy-2-nitrophenyl)pyridine-3-carboxamide (10), with a
33 ication of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl
34 , ethyl-2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carbo xylate) (CXL017),
35 of ethyl 2-amino-6-cyclopentyl-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carbox ylate (1, HA 14-
36 ethyl 2-amino-6-(3',5'-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxyla te (5q, CXL01
37 alogue of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (6, HA 14-1
38 nduced by ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA14-1), a
39 we have demonstrated that ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4H-chromene-3-carboxylate (5
40 ibitors [ethyl [2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3-carboxylate (HA14-1),
42 ll phenolic units blocked, and a dimer, 1-(4-ethoxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-
44 2-(R)-{1-(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(R)-(3,4-difluor ophenyl)-4-(R)-tetrahydro-2H-
45 target daunomycin glucuronide, N-[(4"RS)-4"-ethoxy-4"-(sodium 1"'-O-beta-D-glucopyranuronate)butyl]d
46 benzodioxolane-5-carboxylic acid 3'-bromo-5'-ethoxy-4'-hydroxybenzylidene-hydrazide), an analog of co
47 in or doxorubicin with methyl 1-O-[(1'RS)-1'-ethoxy-4'-oxobutyl]-2,3,4-tri-O-acetyl-beta-D- glucopyra
48 thoxy-4-(trifluoromethyl)coumarin (7-MFC), 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC), 7-benzyloxy-
49 owed the highest catalytic efficiency with 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC), followed by
51 the substrate benzphetamine, the K(m) for 7-ethoxy-4-(trifluoromethyl)coumarin, or the benzphetamine
54 to rotate upward to give testosterone and 7-ethoxy-4-trifluoromethylcoumarin access to the heme, whi
55 sed on the H(2)O(2)-dependent oxidation of 7-ethoxy-4-trifluoromethylcoumarin, and identification of
56 S)-5-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorop henyl)octahydro-2H-isoindol-2-yl]cy
57 ed that one potent salicylaldehyde analog, 3-ethoxy-5,6-dibromosalicylaldehyde, is a non-competitive
58 imidine derivatives as well as 2-(4-benzyl-3-ethoxy-5-methyl-1H-pyrazol-1-yl)-5-methylpyridine, we de
59 e iterative process that, from 2-(4-benzyl-3-ethoxy-5-methyl-1H-pyrazol-1-yl)pyrimidine, led to 2-(4-
60 dyl compound STS-E412 (2-[2-(4-chlorophenoxy)ethoxy]-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine),
61 nzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahy dro-2H-pyran-4-yloxy)quinazolin-4-ami
62 romodiphenyl ether (6,6'-diMeO-BDE194) and 6-ethoxy-6'-methoxy-2,2',3,3',4,4',5,5'-octabromodiphenyl
64 2',2'-trifluoroethoxy)-6-oximinoestradiol, 2-ethoxy-6-oximinoestradiol, and 2-ethoxy-6-methoximinoest
65 bin, the steroid derivative 17beta-acetoxy-2-ethoxy-6-oxo-B-homo-estra-1,3,5(10)-trien-3-ol, and cycl
66 the identification of 4-(2-(azetidin-2(S)-yl)ethoxy)-7-chloro-2-oxo-3-(3,4,5-trimethylphenyl)-1, 2-di
67 formation of 2-(2-(1H-benzo[d]imidazol-1-yl)ethoxy)acetaldehyde (12) and 2-(1H-benzo[d]imidazol-1-yl
68 es contain an N-terminal 2-(2-(2-aminoethoxy)ethoxy)acetic acid (PEG) moiety that makes them cell per
69 ptide, poly(N(epsilon)-2-[2-(2-methoxyethoxy)ethoxy]acetyl-lysine) (1), has been studied using optica
72 de metho-p-toluenesulfonate (CMCT), and beta-ethoxy-alpha-ketobutyraldehyde (kethoxal, KT) are widely
73 -benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide (AZD6244/ARRY142886), 2-(4-morpholinyl)-8-
74 ne 1 (diethyl (1-(tert-butyl(1-(pyridin-4-yl)ethoxy)amino)-2,2-dimethylpropyl)phosphonate) and its N(
81 rone, imipramine and 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A) strongly inhibited
82 ht to reside in close proximity to the pro-S-ethoxy arm of the paraoxon substrate, was mutated to arg
84 Pioglitazone (5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione, 2) is a prototypic
86 onyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carb onyl]hydrazine (KS119), requires enzymatic n
87 4'-(3-methyl-4-(((1(R)-(3-(11)C-methylphenyl)ethoxy)carbonyl)amino)isoxazol-5 -yl)-[1,1'-biphenyl]-4-
88 gral injection of the receptor inactivator N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 50
93 port activity of MDR1 Pgp with ((67/68)Ga-[3-ethoxy-ENBDMPI])(+) may enable noninvasive SPECT/PET mon
94 thyl-3- amino-propyl)ethylenediamine) (Ga-[3-ethoxy-ENBDMPI])(+), as a candidate SPECT ((67)Ga) and g
95 (1R-1-benzo thiophen-5-yl-2[2-diethylamino)-ethoxy] ethanol hydrochloride (T-588) prevented long-ter
96 ist, 2-{2-[4-(3-phenoxybenzyl)piperazin-1-yl]ethoxy}ethanol (ZK 756326), for the CC chemokine recepto
97 omeric bis-N,N'-(2-(2-(2-(2-thioacetylethoxy)ethoxy)ethoxy)ethyl)perylenetetracar boxylic diimide.
98 with (E)-4-(2-(6-(2-(2-(2-(18)F-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methy l benzenamine
100 anediamine, 1,8-octanediamine, 2-[2-(2-amino-ethoxy)-ethoxy]-ethylamine, homospermidine, and homosper
101 [2-{2-([(18)F]fluoroethoxy)-ethoxy}-ethoxy] -ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide ([(1
102 -[2-{2-((18)F-fluoroethoxy)-ethoxy}-ethoxy]- ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide) ((1
103 [2-{2-(2-[2-{2-([(18)F]fluoroethoxy)-ethoxy}-ethoxy] -ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acryla
104 -[2-{2-(2-[2-{2-((18)F-fluoroethoxy)-ethoxy}-ethoxy]- ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acryla
105 o]-7-{2-[2-{2-(2-[2-{2-([(18)F]fluoroethoxy)-ethoxy}-ethoxy] -ethoxy)-ethoxy}-ethoxy]-quinazoline-6-y
106 no]-7-(2-[2-{2-(2-[2-{2-((18)F-fluoroethoxy)-ethoxy}-ethoxy]- ethoxy)-ethoxy}-ethoxy]-quinazoline-6-y
107 (18)F]fluoroethoxy)-ethoxy}-ethoxy] -ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide ([(18)F]F-PE
108 (18)F-fluoroethoxy)-ethoxy}-ethoxy]- ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide) ((18)F-PEG(
109 ement of N-[2-[2-[2-[(N-biotinylcaproylamino)ethoxy)ethoxyl]-4-[2-(trifluoromethyl)-3H-dia zirin-3-yl
110 these compounds (methyl 2-[1-(2-nitrophenyl)ethoxy]ethyl phosphate, 9) was studied in detail by a co
111 ne, 1,8-octanediamine, 2-[2-(2-amino-ethoxy)-ethoxy]-ethylamine, homospermidine, and homospermine cov
112 ylglycine-block-poly-N-2-(2-(2-methoxyethoxy)ethoxy)ethylglyci ne (pNeh-b-pNte) and poly-N-decylglyci
113 ylglycine-block-poly-N-2-(2-(2-methoxyethoxy)ethoxy)ethylglycine (pNdc-b-pNte) with 18 monomer units
114 ylglycine-block-poly-N-2-(2-(2-methoxyethoxy)ethoxy)ethylglycine (pNdc-b-pNte) with volume fraction o
115 ock copolymers, poly(N-2-(2-(2-methoxyethoxy)ethoxy)ethylglycine)-block-poly(N-(2-ethylhexyl)glyc ine
116 reactive reagent (18)F-(2-(2-(2-fluoroethoxy)ethoxy)ethylsulfonyl)ethane ((18)F-DEG-VS) was facilely
118 group at the 3-position, 2-(2(S)-azetidinyl)ethoxy group at the 4-position, and N-4-pyrimidinylcarbo
124 -2-(4-methylpiperazin+ ++- 1-yl)thiazol-4-yl]ethoxy inverted question markphenyl)propionic acid (24)
125 symmetric mixture of methyl, methoxy, ethyl, ethoxy, isopropoxy, phenyl, phenoxy, cyclohexyl, and cyc
126 ropoxy versus the 2-(6-methylamino-2-pyridyl)ethoxy) led to improved activity toward alpha(v)beta(3).
127 with cyclic basic amine groups attached via ethoxy linkages at the C-8 position were the most active
128 2(S)-azetidinylmethoxy]pyridine (A-85380), 5-ethoxy-metanicotine (TC-2559), cytisine, and 3-Br-cytisi
129 on that proceeds through C-H addition of the ethoxy methyl group followed by beta-aryl oxide eliminat
130 ing up with 2-tetrahydropyranyloxy methyl or ethoxy methyl have been shown to follow the alternative
131 dazole (8a) was condensed with [2-(benzyloxy)ethoxy]-methyl chloride (9) and [1,3-bis(benzyloxy)-2-pr
134 ryl oximes formed during reactivation of the ethoxy methylphosphonyl-AChE conjugate by LuH6 and TMB4
135 nyl oximes formed during the reactivation of ethoxy methylphosphonyl-AChE conjugate with LuH6 and TMB
137 olyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)n aphthalen-1-yl]urea (BIRB 796), an inhibitor of
141 g adduct after quenching in methanol; for [1-ethoxy-(N-ethoxycarbonyl)formimidoyl](N'-methyl-N'-pheny
142 ed conditions stop at the (chlorocarbonyl)[1-ethoxy-(N-ethoxycarbonyl)formimidoyl]disulfane intermedi
143 h a specific nucleophile reactive inhibitor, ethoxy oleoyl fluorophosphonate, identified S241 as the
145 stion mark4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phen yl inverted question mark ethylamino)benzoic
146 th oxygen ([6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene h
147 zoxifene ([6-hydroxy-3-[4-[2-(1-piperidinyl)-ethoxy]phenoxy]-2-(4-methoxyphenyl)]be nzo[b]thiophene)
148 he reaction is catalytic for p-methoxy and p-ethoxy phenyl azides, while no azoarene is observed for
149 estion mark4-[2-(methylpyridin-2-ylamino+ ++)ethoxy ]phenyl inverted question markpropionic acid (18)
150 romobenzyloxy)-4-[4-(2-naphthalen-1-yl-2-oxo-ethoxy)phenyl]p iperidine) has been studied using steady
151 uestion mark4-[2-(benzoxazol-2-ylmethylamino)ethoxy]phenyl inverted question mark-(2S)-((2- benzoylph
152 uestion mark4-[2-(Benzoxazol-2-ylmethylamino)ethoxy]phenyl inverted question mark-(2S)-((2- benzoylph
153 -[2-(5-methyl-2-pyridin-4-yloxazol+ ++- 4-yl)ethoxy]phenyl inverted question markpropionic acid (16)
154 l)methane, vis., 4-[2-(6-amino-9H-purin-9-yl)ethoxy]phenyl-4-[bis(2,2'-bithienyl)methane] or Ade-BTM,
155 -[4-[2-(5-methyl-2-thiophen-2-yl-oxazol-4-yl)ethoxy]phenyl]- 2-phenoxypropionic acid (2) for the trea
156 iodotamoxifen [2a,(E)-1-[4-(N-dimethylamino)-ethoxy]phenyl]-1-(4-iodophenyl)-2-phenyl -1-butene] with
157 droxyphenyl)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H- 1-benzopyran-7-ol (EM652), and the am
158 roxybenzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (2), is representa
159 arboxy-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl}ethy lamino)benzoic acid methyl ester) ((1
160 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-yl-ethoxy)phenylamino]benzo[1,2,4]triaz in-7-yl}phenol ( 5)
161 6-dioxocyclo-hexylidene)-3-[2-(2-aminoethoxy)ethoxy]-pro pan-1-ol, a heterobifunctional traceless lin
162 zol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylm ethoxy)pyrazolo[1,5-d][1,2,4]triazine (13) has been iden
163 uoroethoxy)-ethoxy}-ethoxy] -ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide ([(18)F]F-PEG6-IPQA)
164 uoroethoxy)-ethoxy}-ethoxy]- ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide) ((18)F-PEG(6)-IPQA)
165 iple, from a 1,2-hydrogen shift and/or a 1,2-ethoxy shift in the carbene, a deuterium labeling study
166 th a Si(100)-hydrogen terminated wafer, a Si-ethoxy (Si-OC2H5) surface intermediate forms due to DEC
168 ligomers of the same length with and without ethoxy solubilizing groups reveals that both solubilized
171 s (4-phenyl and 4-cyano with N-methoxy and N-ethoxy substituents) led to a consistent set of kinetic
173 surfaces indicates the equatorial form of 2-ethoxy tetrahydropyran is more sensitive to solvent than
174 uatorial anomers of the model carbohydrate 2-ethoxy tetrahydropyran to evaluate the level of theory r
175 ion of benzphetamine and O-deethylation of 7-ethoxy-trifluoromethylcoumarin as the WT did, whereas th
176 difference in effects of methyl, methoxy, or ethoxy), two side chains bearing 1-naphthyl groups, and
177 TX-series with a large number (n = 30-70) of ethoxy units, which were initially found to exhibit extr
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。